In recent years, growing evidences have indicated that ZEB1 (also known as TCF8, AREB6, ZFHEP, ZFHX1α, BZP, NIL-2α, deltaEF1) plays vital roles in EMT and cancer metastasis and its higher expression correlates with poor clinical outcomes in HCC patients 16-18. Here, ZEB1 is linked to cancer.